Meal Timing Impact on Neurological Health in MS
Understanding the Impact of Meal Timing on Neurological Health in Adults With Multiple Sclerosis
Recruiting
N/A
Interventional Study
Multiple Sclerosis
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 – 64
- Sex
- Any
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 22 (estimated)
- Sponsor
- University of Alabama at Birmingham · Other
Who this trial is looking for
This trial is looking for adults with multiple sclerosis to learn if when they eat affects their neurological health. Participants will need to eat at specific times each day and report their eating schedule via smartphone prompts.
Are You a Good Fit for This Trial?
You may be able to join if
- I have been diagnosed with relapsing remitting or secondary progressive multiple sclerosis.
- I have been stable on any disease modifying therapy for 6 months.
- I have not used disease modifying therapies in the past 6 months.
- I have a BMI between 18.5 and 50.
- I have access to a smartphone.
- I can manage my own eating schedule.
You may not be able to join if
- I have had a relapse in the past 30 days.
- I am actively engaged in a weight loss program.
- I currently use GLP-1 medications or have used them in the past 3 months.
- I regularly fast for more than 12 hours a day.
- I work night shifts or rotating shifts.
- I cannot walk 25 feet with or without an assistive device.
- I currently use insulin or sulfonylureas.
- I am pregnant or breastfeeding.
Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.
Think this trial could be right for you?
Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.
Check Your Eligibility
About This Trial
The goal of this clinical trial is to learn if the time an individual eats each day impacts neurological health in people with multiple sclerosis. The main questions the investigators are asking are:
1. Does meal timing affect biomarkers of neuronal health (neurofilament light chain \[NfL\] and BDNF) and inflammation (IL-6, IL-17, TNF-ɑ) in adults with MS.
2. Does meal timing affect expression of…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Diagnosed with relapsing remitting or secondary progressive multiple sclerosis (RRMS or SPMS)
* If on disease modifying therapy (DMTs), stable for 6 months
* If not on DMTs, no DMT usage within previous 6 months
* BMI 18.5-50 kg/m2
* Access to a smartphone
* Responsible for pe…
Contacts